Peter M. Castleman

CIK: 0001239594

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAI

Caris Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CAI
Caris Life Sciences, Inc.
Aug 14, 2026
Award(A)
Direct
13.2K shares-
CAI
Caris Life Sciences, Inc.
Feb 26, 2026
Award(A)
Direct
5.5K shares at avg. $20.06$111K
CAI
Caris Life Sciences, Inc.
Jan 9, 2026
Exercise(M)
Direct
2.5K shares at avg. $18.60$47K
CAI
Caris Life Sciences, Inc.
Jun 20, 2025
Conversion(C)
Indirect
10.2M shares-
CAI
Caris Life Sciences, Inc.
Feb 27, 2025
Award(A)
Direct
16.1K shares-

		Type	Shares	Price		Ownership
Aug 14, 2026	CAI Caris Life Sciences, Inc.	Award(A)	13,192	-	$0	Direct
Feb 26, 2026	CAI Caris Life Sciences, Inc.	Award(A)	5,509	$20.06	$110,511	Direct
Jan 9, 2026	CAI Caris Life Sciences, Inc.	Exercise(M)	2,500	$18.60	$46,500	Direct
Jun 20, 2025	CAI Caris Life Sciences, Inc.	Conversion(C)	10,245,906	-	-	Indirect
Feb 27, 2025	CAI Caris Life Sciences, Inc.	Award(A)	16,129	-	-	Direct

1-5 of 5 transactions

About CASTLEMAN PETER M

CASTLEMAN PETER M (SEC CIK 0001239594) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI).

Signal8 holds 5 ownership filings by CASTLEMAN PETER M (1 Form 3, 4 Form 4), filed between Jun 17, 2025 and Aug 14, 2026. Those filings report 5 transactions, from Feb 27, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CASTLEMAN PETER M's filings is in IRVING, TX.

Recent filings by CASTLEMAN PETER M

Aug 14, 2026: Grant or award of CAI shares (Form 4, code A).
Feb 26, 2026: Grant or award of CAI shares (Form 4, code A).
Jan 9, 2026: Option exercise of CAI shares (Form 4, code M).
Jun 20, 2025: Conversion of CAI shares (Form 4, code C).
Feb 27, 2025: Grant or award of CAI shares (Form 4, code A).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes